Investing Ideas
/
U.S. Pharmaceuticals & Biotech Precious Metals

U.S. Pharmaceuticals & Biotech Precious Metals

Results

136

0 new

Gold, Silver and Precious Metals companies ordered by Snowflake size.

136 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ICPT Intercept Pharmaceuticals	US$19.00	0.1%	19.1%	US$794.7m	US$19.00	PS2.5x	E42.4%	n/a
CRMD CorMedix	US$8.23	17.4%	123.0%	US$433.5m	US$12.50	PS570.3x	E65.6%	n/a
ATYR aTyr Pharma	US$1.74	-7.0%	9.4%	US$130.4m	US$22.00	PS224.3x	E67.4%	n/a
ANTX AN2 Therapeutics	US$1.06	-2.3%	-93.4%	US$31.3m	US$2.67	PB0.3x	E69.8%	n/a
MDWD MediWound	US$16.72	-5.6%	53.8%	US$183.3m	US$29.75	PS9x	E56.2%	n/a
ANIK Anika Therapeutics	US$24.63	-2.9%	30.5%	US$365.3m	US$34.50	PS2.2x	E121.6%	n/a
SPPI Spectrum Pharmaceuticals	US$1.03	5.3%	17.0%	US$209.9m	US$1.26	PS8.2x	E67.3%	n/a
QNRX Quoin Pharmaceuticals	US$0.53	-8.7%	-87.7%	US$2.1m	US$4.67	PB0.3x	E53.0%	n/a
AYTU Aytu BioPharma	US$2.85	18.7%	6.7%	US$14.5m	US$8.00	PB0.6x	E96.2%	n/a
IOVA Iovance Biotherapeutics	US$9.25	-10.6%	102.9%	US$2.8b	US$24.42	PS85.7x	E66.3%	n/a
AVXL Anavex Life Sciences	US$5.67	-1.6%	-15.6%	US$462.1m	US$35.47	PB3.7x	E61.5%	n/a
LLY Eli Lilly	US$909.32	-0.6%	67.0%	US$832.5b	US$995.42	PE111.5x	E28.5%	0.6%
MIRM Mirum Pharmaceuticals	US$38.70	-1.7%	22.6%	US$1.9b	US$59.27	PS7x	E69.8%	n/a
MIST Milestone Pharmaceuticals	US$1.51	-2.6%	-50.2%	US$99.9m	US$10.25	PB3.1x	E61.8%	n/a
SCPH scPharmaceuticals	US$4.42	-16.0%	-36.9%	US$232.1m	US$19.80	PS9.2x	E66.3%	n/a
AUPH Aurinia Pharmaceuticals	US$7.16	-0.6%	-9.1%	US$1.0b	US$9.77	PS4.9x	E54.6%	n/a
GERN Geron	US$4.43	-6.5%	110.0%	US$2.7b	US$7.31	PS1944.9x	E68.0%	n/a
ARCT Arcturus Therapeutics Holdings	US$21.77	3.6%	-14.4%	US$576.3m	US$77.26	PS3.6x	E68.2%	n/a
TSVT 2seventy bio	US$4.76	-2.3%	25.9%	US$222.5m	US$8.25	PS5.6x	E76.5%	n/a
CING Cingulate	US$5.14	0%	-97.0%	US$11.2m	US$72.50	PB3.6x	E65.6%	n/a
HZNP Horizon Therapeutics	US$116.30	0.06%	82.8%	US$26.6b	US$116.50	PE60.8x	E16.4%	n/a
ARTL Artelo Biosciences	US$1.08	-4.1%	-27.0%	US$3.5m	US$5.00	PB0.5x	E59.6%	n/a
CYCC Cyclacel Pharmaceuticals	US$1.00	-2.0%	-80.6%	US$2.0m	US$11.00	PS24.7x	E71.5%	n/a
DVAX Dynavax Technologies	US$10.85	-5.7%	-26.5%	US$1.4b	US$24.60	PE82.8x	E38.5%	n/a

Page 4 of 6